Lindquist D, Hellberg D, Tot T
Department of Pathology and Clinical Cytology, Central Hospital Falun, SE-791 82 Falun, Sweden.
Patholog Res Int. 2011;2011:860584. doi: 10.4061/2011/860584. Epub 2011 Aug 10.
Despite improvements of the therapy for breast cancer, a proportion of the patients still get local recurrence. The status of the surgical margins is the most often used parameter for decision regarding additional treatment. However, a negative margin is not a guarantee that there is not residual cancer left in the breast; additional parameters are needed to better predict the risk of local recurrence. The disease extent was evaluated in the surgical specimen from 313 women after breast-conserving therapy using large-section histology and was correlated to the incidence of local recurrence. A disease extent ≥4 cm was shown to be an independent marker for local recurrence; the cumulative 10-year local relapse rate for the group with a disease extent ≥4 cm was 20.5%, and for the rest 6.7%. We conclude that disease extent ≥4 cm seems to be an important factor when evaluating the risk for local recurrence.
尽管乳腺癌治疗方法有所改进,但仍有一部分患者会出现局部复发。手术切缘状态是决定是否进行额外治疗时最常用的参数。然而,切缘阴性并不能保证乳房内没有残留癌症;还需要其他参数来更好地预测局部复发风险。采用大切片组织学方法对313例保乳治疗后的女性手术标本中的疾病范围进行了评估,并将其与局部复发发生率相关联。结果显示,疾病范围≥4 cm是局部复发的独立标志物;疾病范围≥4 cm组的10年累计局部复发率为20.5%,其余组为6.7%。我们得出结论,在评估局部复发风险时,疾病范围≥4 cm似乎是一个重要因素。